Andrei Trapeznikov: "Nuclear medicine is an important social project for Rosnano"
8 years ago, in March of 2001, as a result of reorganization of the Russian Corporation of Nanotechnologies, the Rosnano company was established. Anatoly Chubais, chairman of the board of directors of the company and chairman of the board of the Infrastructure and Educational Programs Fund, says that state managed to get back all the money it spend on creating this corporation. One of the most important projects for Rosnano is nuclear medicine. Andrei Trapeznikov, deputy chairman of the external communications board of Rosnano, disccused medical projects of the company in an interview with Vestnik Kavkaza.
- What medical and technological projects of Rosnano are in demand?
- One of our main projects is nuclear medicine centers. We have created 11 centers in 10 regions. They have already carried out examination of over 100 thousand people. These centers diagnose oncology diseases at early stage, when treatment is much more effective, and percentage of people who can then continue to work and live is much more than compared to later stages.
Right we and out partners create a foundation that will work on similar projects. In addition to diagnostics, we're also perform operations using cyberknife systed. Over one and a half thousand people have gone through such operations. It's a transfer-technology, but we upgraded it using Russia's scientific and technological base.
- Do nuclear medicine centers deal only with oncology?
- Today we want to move to diagnosis of vascular diseases in these centers. It's a socially significant project. And we don't receive money from the state, since we've created a system that allows people to receive help from nuclear medicine centers using free medical insurance policy. In addition, we tried (and we succeeded in it) to transport necessary equipment from Khabarovsk to Vladivostok to diagnose people right where they live. Khabarovsk has a center where radioactive substance is produced, which is necessary for diagnosis, and Vladivostok didn't have necessary ficility. We're first in Russia to do this. Regional authorities helped us, Aeroflot helped us, and we delivered equipment. We're also thinking about using drones. It's an interesting project, it's socially significant. When you see patients who are able to survive thanks to our work, it's really worth it.